Yield10 Bioscience (YTEN) Financials

$0.02

$0.00 (0.00%)

As on 21-Feb-2025 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$1 Mln

P/E Ratio

--

P/B Ratio

11.2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	0.81	0.06	0.45	0.61	0.80	0.81
Cost of Revenue	0.15	0.29	0.66	0.58	5.22	4.85
Gross Profit	0.68	-0.23	-0.21	0.04	-4.42	-4.04
Operating Expenses	13.40	14.48	13.90	12.31	10.41	9.40
Operating Profit (EBIT)	-12.59	-14.42	-13.45	-11.69	-9.61	-8.60
Other Income	--	--	--	--	-0.54	-4.61
Profit before Tax	-12.70	-14.46	-13.41	-11.00	-10.15	-13.21
Provision for Tax	-0.20	0.12	0.16	0.04	0.06	-0.25
Profit after Tax (Net Income)	-12.70	-14.46	-13.57	-11.03	-10.21	-12.96
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	-13.57	-11.03	-10.21	-12.96

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	-6.24	-2.48	4.40	16.03	9.53	-4.09
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.54	1.53	2.08	2.66	3.18	18.60
Current Liabilities	7.67	4.87	1.61	1.73	1.81	2.21
Total Liabilities	10.64	3.91	8.09	20.42	14.52	16.72

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	1.76	2.51	3.07	3.79	4.18	5.03
Current Assets	1.20	1.40	5.02	16.62	10.34	11.68
Total Assets	10.64	3.91	8.09	20.42	14.52	16.72
Total Debt*	2.79	3.21	2.65	3.16	3.62	4.22
Net Current Assets	-6.47	-3.47	3.41	14.89	8.53	9.48

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	-10.07	-11.40	-9.25	-8.66	-8.65
Cash Flow from Investing Activities	--	--	8.52	-4.58	-0.65	-3.02
Cash from Financing Activities	--	6.87	-0.04	15.75	7.28	14.08
Net Cash Inflow / Outflow	--	--	--	--	-2.03	2.41

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	-371.98	-103.40	-68.22	-153.61	-209.83
ROE (%)	--	-1,508.09	-132.83	-86.32	-374.74	-1,606.45
ROA (%)	-133.87	-241.08	-95.20	-63.15	-65.34	-87.31
EBIT Margin (%)	-1,153.83	-24,028.33	-3,076.44	-1,962.54	-1,256.32	-1,066.50
Net Margin (%)	-1,568.15	-24,091.67	-3,014.67	-1,796.58	-3,955.81	340.23
Cash Profit Margin (%)	-0.01	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	213.95	-0.87	-0.27	-0.23	-0.01	0.45
EBIT Growth (%)	34.31	-4.14	-14.89	-20.04	-16.78	7.76
Net Profit Growth (%)	10.78	-6.55	-22.98	-8.08	21.23	-41.06
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	--	--	--	--	--	--
Price / Book Value	11.23	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.49	-0.15	0.13	1.12	0.65	1.40
Close Price ($)	1.20	0.24	1.67	4.92	5.78	6.86
High Price ($)	7.16	4.19	7.21	23.49	14.69	70.70
Low Price ($)	0.18	0.18	1.63	3.98	3.50	4.48
Market Cap ($ Cr)	0.35	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	--	-1.29	0.60	0.20	0.38	-1.03
Short term debt to equity ratio	-0.27	-0.55	0.28	0.07	0.12	-0.15
Current Ratio	0.16	0.29	3.12	9.59	5.70	5.29
Quick Ratio	0.16	--	3.12	--	--	5.29
Interest Coverage	-704.67	--	-337.66	-8.63	-8.62	-0.66

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	--	--	6.67	32.25	14.14	11.41
Asset Turnover	0.09	0.01	0.03	0.04	0.05	0.05
Receivable days	--	182.63	92.53	92.50	46.86	57.10
Inventory Days	--	0.00	0.00	--	0.00	0.00
Payable days	--	825.59	53.45	45.18	11.86	14.92
Cash Conversion Cycle	--	-642.96	39.08	--	35.00	42.18

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.